.ANALYSIS EMPHASIZE.06 August 2024.
A big randomized measured test with cisgender females highlights the difficulties of faithfulness to a day-to-day oral preexposure prevention regiment as well as shows that twice-yearly injection of lenacapavir can easily preserve successful HIV deterrence levels over 6 months.